{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T03:36:39Z","timestamp":1769398599371,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The carbohydrate antigen 125 (CA125) was proven as a robust biomarker for risk stratification in adults with heart failure. This is the first study analyzing CA125 in a cohort of infants with congenital diaphragmatic hernia (CDH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-eight infants with CDH, treated at the University Children\u2019s Hospital Bonn (Germany), between January 2018 and February 2021, were prospectively enrolled for analysis. CA125 values were measured at the following timepoints: 6,12, 24, 48\u2009h, and during ECMO daily from day 1 to day 7.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In infants not surviving to discharge, CA125 values were significantly higher at day 1 (6, 12, and 24\u2009h). Infants with subsequent need for ECMO presented significantly higher CA125 values at 12\u2009h of life. During ECMO, CA125 values measured at day 1 were significantly higher in infants not surviving to discharge. In the ROC analysis, a CA125 value of \u226510\u2009U\/ml was calculated as optimal cut-off for the prediction of ECMO and in-hospital mortality. CA125 values correlated significantly with the severity of PH and ventricular dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CA125 values correlate significantly with echocardiographic markers of PH and ventricular dysfunction and correlate significantly with parameters of disease severity (need for ECMO, mortality).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>CA125 was proven as robust cardiac biomarker in adult cohorts.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Information about the utility as a biomarker in neonatal cohorts is lacking.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>This is the first study analyzing CA125 as a cardiac biomarker in a cohort of infants with congenital diaphragmatic hernia (CDH).<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>CA125 correlates significantly with markers of echocardiographic assessment (PH and ventricular dysfunction) in infants with CDH and helps to identify infants at high risk for ECMO and in-hospital mortality.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The results underline the need for the inclusion of cardiac biomarkers in the clinical routine in neonates at risk for cardiopulmonary failure.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-022-02130-8","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T16:04:47Z","timestamp":1655309087000},"page":"682-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia"],"prefix":"10.1038","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-2243","authenticated-orcid":false,"given":"Lukas","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaminia","family":"Pugnaloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Dolscheid-Pommerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annegret","family":"Geipel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Holdenrieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Kipfmueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2130_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000444210","volume":"110","author":"KG Snoek","year":"2016","unstructured":"Snoek, K. G. et al. Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: The CDH EURO Consortium Consensus - 2015 update. Neonatology 110, 66\u201374 (2016).","journal-title":"Neonatology"},{"key":"2130_CR2","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1164\/rccm.201904-0731OC","volume":"200","author":"N Patel","year":"2019","unstructured":"Patel, N. et al. Ventricular dysfunction is a critical determinant of mortality in congenital diaphragmatic hernia. Am. J. Respir. Crit. Care Med. 200, 1522\u20131530 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2130_CR3","doi-asserted-by":"publisher","first-page":"105049","DOI":"10.1016\/j.earlhumdev.2020.105049","volume":"146","author":"K Heindel","year":"2020","unstructured":"Heindel, K. et al. Early postnatal changes of circulating N-terminal-pro-B-type natriuretic peptide in neonates with congenital diaphragmatic hernia. Early Hum. Dev. 146, 105049 (2020).","journal-title":"Early Hum. Dev."},{"key":"2130_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jpeds.2016.03.026","volume":"173","author":"KG Snoek","year":"2016","unstructured":"Snoek, K. G. et al. High-sensitivity troponin T and N-terminal pro-brain natriuretic peptide in prediction of outcome in congenital diaphragmatic hernia: results from a multicenter, randomized controlled trial. J. Pediatr. 173, 245\u2013249 (2016).","journal-title":"J. Pediatr."},{"key":"2130_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000112641","volume":"94","author":"MJ Baptista","year":"2008","unstructured":"Baptista, M. J. et al. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants. Neonatology 94, 22\u201330 (2008).","journal-title":"Neonatology"},{"key":"2130_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpedsurg.2021.02.042","volume":"56","author":"VS Gupta","year":"2021","unstructured":"Gupta, V. S. et al. Elevated proBNP levels are associated with disease severity, cardiac dysfunction, and mortality in congenital diaphragmatic hernia. J. Pediatr. Surg. 56, 1214\u20131219 (2021).","journal-title":"J. Pediatr. Surg."},{"key":"2130_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/pr.2014.136","volume":"76","author":"MA Steurer","year":"2014","unstructured":"Steurer, M. A. et al. B-type natriuretic peptide: a prognostic marker in congenital diaphragmatic hernia. Pediatr. Res. 76, 549\u2013554 (2014).","journal-title":"Pediatr. Res."},{"key":"2130_CR8","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3906\/sag-1609-13","volume":"47","author":"A Pekta\u015f","year":"2017","unstructured":"Pekta\u015f, A. et al. Biomarker and shear stress in secondary pediatric pulmonary hypertension. Turk. J. Med. Sci. 47, 1854\u20131860 (2017).","journal-title":"Turk. J. Med. Sci."},{"key":"2130_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jchf.2016.06.007","volume":"4","author":"J N\u00fa\u00f1ez","year":"2016","unstructured":"N\u00fa\u00f1ez, J. et al. Carbohydrate antigen-125-guided therapy in acute heart failure: CHANCE-HF: a randomized study. JACC Heart Fail. 4, 833\u2013843 (2016).","journal-title":"JACC Heart Fail."},{"key":"2130_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jcp.47.3.263","volume":"47","author":"AM Zeillemaker","year":"1994","unstructured":"Zeillemaker, A. M., Verbrugh, H. A., van Hoynck Papendrecht, A. A. & Leguit, P. CA 125 secretion by peritoneal mesothelial cells. J. Clin. Pathol. 47, 263\u2013265 (1994).","journal-title":"J. Clin. Pathol."},{"key":"2130_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/bjc.1984.254","volume":"50","author":"PA Canney","year":"1984","unstructured":"Canney, P. A., Moore, M., Wilkinson, P. M. & James, R. D. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br. J. Cancer 50, 765\u2013769 (1984).","journal-title":"Br. J. Cancer"},{"key":"2130_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejheart.2005.09.002","volume":"8","author":"F Kosar","year":"2006","unstructured":"Kosar, F., Aksoy, Y., Ozguntekin, G., Ozerol, I. & Varol, E. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur. J. Heart Fail. 8, 270\u2013274 (2006).","journal-title":"Eur. J. Heart Fail."},{"key":"2130_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/eurjhf\/hfr022","volume":"13","author":"MB Yilmaz","year":"2011","unstructured":"Yilmaz, M. B., Nikolaou, M. & Cohen Solal, A. Tumour biomarkers in heart failure: is there a role for CA-125? Eur. J. Heart Fail. 13, 579\u2013583 (2011).","journal-title":"Eur. J. Heart Fail."},{"key":"2130_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1253\/jcj.57.489","volume":"57","author":"T Seo","year":"1993","unstructured":"Seo, T. et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn. Circ. J. 57, 489\u2013494 (1993).","journal-title":"Jpn. Circ. J."},{"key":"2130_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000074425","volume":"24","author":"HM Turk","year":"2003","unstructured":"Turk, H. M. et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol. 24, 172\u2013175 (2003).","journal-title":"Tumour Biol."},{"key":"2130_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1378\/chest.105.3.897","volume":"105","author":"DL Mann","year":"1994","unstructured":"Mann, D. L. & Young, J. B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105, 897\u2013904 (1994).","journal-title":"Chest"},{"key":"2130_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1631560","volume":"257","author":"MS Finkel","year":"1992","unstructured":"Finkel, M. S. et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257, 387\u2013389 (1992).","journal-title":"Science"},{"key":"2130_CR18","first-page":"648","volume":"34","author":"T Schaible","year":"2017","unstructured":"Schaible, T. et al. Are cytokines useful biomarkers to determine disease severity in neonates with congenital diaphragmatic hernia? Am. J. Perinatol. 34, 648\u2013654 (2017).","journal-title":"Am. J. Perinatol."},{"key":"2130_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/eurheartj\/ehq142","volume":"31","author":"J N\u00fa\u00f1ez","year":"2010","unstructured":"N\u00fa\u00f1ez, J. et al. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur. Heart J. 31, 1752\u20131763 (2010).","journal-title":"Eur. Heart J."},{"key":"2130_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0735-1097(03)00311-5","volume":"41","author":"A D\u2019Aloia","year":"2003","unstructured":"D\u2019Aloia, A. et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J. Am. Coll. Cardiol. 41, 1805\u20131811 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2130_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2020.03.027","volume":"308","author":"M Soler","year":"2020","unstructured":"Soler, M. et al. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation. Int. J. Cardiol. 308, 54\u201359 (2020).","journal-title":"Int. J. Cardiol."},{"key":"2130_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/SMJ.0b013e318229a55c","volume":"104","author":"O Uz","year":"2011","unstructured":"Uz, O. et al. CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD. South Med. J. 104, 624\u2013628 (2011).","journal-title":"South Med. J."},{"key":"2130_CR23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0002-8703(99)70360-1","volume":"137","author":"H N\u00e4gele","year":"1999","unstructured":"N\u00e4gele, H., Bahlo, M., Klapdor, R., Schaeperkoetter, D. & R\u00f6diger, W. CA 125 and its relation to cardiac function. Am. Heart J. 137, 1044\u20131049 (1999).","journal-title":"Am. Heart J."},{"key":"2130_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fped.2018.00079","volume":"6","author":"C Tissot","year":"2018","unstructured":"Tissot, C., Singh, Y. & Sekarski, N. Echocardiographic evaluation of ventricular function for the neonatologist and pediatric intensivist. Front. Pediatr. 6, 79 (2018).","journal-title":"Front. Pediatr."},{"key":"2130_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ejechocard\/jer181","volume":"12","author":"L Mertens","year":"2011","unstructured":"Mertens, L. et al. Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training. Eur. J. Echocardiogr. 12, 715\u2013736 (2011).","journal-title":"Eur. J. Echocardiogr."},{"key":"2130_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67548-8","volume":"10","author":"F Falc\u00e3o","year":"2020","unstructured":"Falc\u00e3o, F. et al. Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction. Sci. Rep. 10, 11016 (2020).","journal-title":"Sci. Rep."},{"key":"2130_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10741-013-9402-y","volume":"19","author":"J N\u00fa\u00f1ez","year":"2014","unstructured":"N\u00fa\u00f1ez, J. et al. Clinical utility of antigen carbohydrate 125 in heart failure. Heart Fail. Rev. 19, 575\u2013584 (2014).","journal-title":"Heart Fail. Rev."},{"key":"2130_CR28","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.2174\/1381612827666210118122521","volume":"27","author":"C Pan","year":"2021","unstructured":"Pan, C. et al. CA125: an increasingly promising biomarker in heart failure. Curr. Pharm. Des. 27, 3871\u20133880 (2021).","journal-title":"Curr. Pharm. Des."},{"key":"2130_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clinbiochem.2020.12.010","volume":"89","author":"A Sahin","year":"2021","unstructured":"Sahin, A., Kaya, H. & Avci, O. Cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension. Clin. Biochem. 89, 58\u201362 (2021).","journal-title":"Clin. Biochem."},{"key":"2130_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.hlc.2011.01.025","volume":"20","author":"A Zorlu","year":"2011","unstructured":"Zorlu, A., Tandogan, I. & Yilmaz, M. B. CA-125, an omitted part of the heart. Heart Lung Circ. 20, 345\u2013346 (2011).","journal-title":"Heart Lung Circ."},{"key":"2130_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1203\/00006450-199511000-00026","volume":"38","author":"P Lahdenne","year":"1995","unstructured":"Lahdenne, P. et al. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors. Pediatr. Res. 38, 797\u2013801 (1995).","journal-title":"Pediatr. Res."},{"key":"2130_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","volume":"2","author":"SE Kabawat","year":"1983","unstructured":"Kabawat, S. E. et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int. J. Gynecol. Pathol. 2, 275\u2013285 (1983).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"2130_CR33","doi-asserted-by":"publisher","first-page":"647541","DOI":"10.1155\/2014\/647541","volume":"2014","author":"G Coppolino","year":"2014","unstructured":"Coppolino, G. et al. Tumour markers and kidney function: a systematic review. Biomed. Res. Int. 2014, 647541 (2014).","journal-title":"Biomed. Res. Int."},{"key":"2130_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2021.08.024","volume":"95","author":"R de La Espriella","year":"2022","unstructured":"de La Espriella, R. et al. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure. Eur. J. Intern. Med. 95, 67\u201373 (2022).","journal-title":"Eur. J. Intern. Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02130-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T15:08:47Z","timestamp":1678115327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02130-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients were prospectively enrolled in the study after informed written consent was obtained from the parents or legal representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}